Effect of calcium supplements on risk of myocardial infarction and cardiovascular events: meta-analysis
The FDA announced that Ozempic and Wegovy supply problems had ended and set final deadlines for pharmacies to stop making compounded semaglutide: Individual pharmacy locations: Required to stop by April 22, 2025 Commercial compounding operations: Discontinue production by May 22, 2025 So, compounded semaglutide was not available after May 22, 2025, except in exceptional medical circumstances where standard formulations are ineffective
A typical 5 mg vial reconstituted with 2 mL of bacteriostatic water creates a concentration of 2.5 mg/mL, where 0.1 mL (10 units on an insulin syringe) contains 0.25 mg
We gotta get some weight off, I am Beatrix, seeing red
However, a small mean increase in resting heart rate (of a few beats per minute) has been noted across GLP-1 medicines as a class, so cardiovascular assessment before treatment and monitoring during it remain appropriate, particularly if you have a heart condition
TB-500's wound closure and collagen organisation effects are similarly well-replicated in rodent wound and ligament models (Malinda et al
